In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.
A limited repertoire of antimicrobial agents is currently in use for the treatment of plague. We investigated the in vitro activities of some newer antimicrobial agents against Yersinia pestis. Among the injectable agents tested, cefotaxime was the most active, and among the oral agents, both levofloxacin and ofloxacin were highly active, with MICs at which 90% of isolates are inhibited of < 0.03 microgram/ml. the susceptibilities to the ketolide RU004 and the penem faropenem warrant attention. The enhanced activities of quinolones against Y. pestis suggest that these agents should be further investigated for the treatment of human plague in the future.
Department of Medical Microbiology, School of Pathology, South African Institute for Medical Research, Johannesburg, South Africa.
J A
JA
Frean
L
L
Arntzen
T
T
Capper
A
A
Bryskier
K P
KP
Klugman
D000353:Africa, Southern; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use; D024841:Fluoroquinolones; D006801:Humans; D008826:Microbial Sensitivity Tests; D010930:Plague / Q000188:drug therapy / Q000382:microbiology*; D015010:Yersinia pestis / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D024841:Fluoroquinolones